Рубрика
Blog
-
2023
-
New method predicts the right treatment for breast cancer patients
-
Gilead Sciences’ Sunlenca Gains FDA Approval for HIV Type 1
-
Study: Survivors of Hodgkin Lymphoma Show Signs of Dementia in Early Adulthood
-
FDA Approves Tocilizumab as First Monoclonal Antibody Treatment of COVID-19
-
FDA Approves Bispecific Antibody Mosunetuzumab-axgb to Treat Relapsed/Refractory Follicular Lymphoma
-
EU Approves Atara’s Ebvallo for Posttransplant Lymphoproliferative Disease
-
FDA Grants Priority Review for Enfortumab Vedotin-ejfv, Pembrolizumab for Treatment of Urothelial Cancer
-
Pfizer files blockbuster hope etrasimod for ulcerative colitis
-
FDA Approves Preservative-Free Latanoprost Drug for Elevated Intraocular Pressure
-
A way to make asthma drugs last longer